Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Medivation Inc (NASDAQ:MDVN)

30.44
Delayed Data
As of Feb 12
 +1.86 / +6.51%
Today’s Change
26.41
Today|||52-Week Range
70.79
-37.03%
Year-to-Date

Today’s Trading

Previous close28.58
Today’s open28.70
Day’s range28.05 - 30.47
Volume3,198,067
Average volume (3 months)1,917,563
Market cap$4.7B
Dividend yield--
Data as of 3:59pm ET, 02/12/2016

Growth & Valuation

Earnings growth (last year)--
Earnings growth (this year)-10.59%
Earnings growth (next 5 years)+28.00%
Revenue growth (last year)+160.31%
P/E ratio19.7
Price/Sales11.92
Price/Book9.94

Competitors

 Today’s
change
Today’s
% change
ALKSAlkermes Plc+1.26+4.04%
OPKOPKO Health Inc-0.11-1.38%
UTHRUnited Therapeutics ...+4.95+4.07%
SGENSeattle Genetics Inc+1.60+5.92%
Data as of 4:00pm ET, 02/12/2016

Financials

Next reporting dateFebruary 26, 2016
EPS forecast (this quarter)$0.84
Annual revenue (last year)$710.5M
Annual profit (last year)$276.5M
Net profit margin38.91%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
David T. Hung
Chief Operating Officer
Marion McCourt
Corporate headquarters
San Francisco, California

Forecasts

Partner Offers